9 Erkang Road, Liuyang Economic and Technological Development Zone, Changsha City, Hunan Province
Sales@erkangpharma.com +86 731 8579 6471 (Office landline)
Hunan Er-kang Pharmaceutical Co., Ltd., founded in 2003, is the largest and most comprehensive pharmaceutical excipient company in China, boasting the widest range of products and the most advanced technology (Stock Code: SZ.300267). It is a leading enterprise in the high-tech sector and a pioneer in the pharmaceutical excipient industry, being the primary architect of China’s pharmaceutical excipient standards and the first to industrialize starch capsules. The company currently offers 127 types of pharmaceutical excipients, 73 active pharmaceutical ingredients (APIs), and has 282 approvals for finished drug products. Among these, the starch-based plant capsule is a core product with global exclusive intellectual property rights, holding over 90 patents. The company’s products are exported to nearly 40 countries and regions worldwide. Erkang has received multiple accolades, including being named a ‘National Torch Program Key High-tech Enterprise’, ‘China’s Most Investment-worthy Pharmaceutical Listed Company’, ‘Top 100 Enterprises in China’s Pharmaceutical Industry’, and inclusion in the ‘Xinhua News Agency National Brand Project’.
In 2013, to further its internationalization strategy, Hunan Erkang (Cambodia) Investment Co., Ltd. established an industrial park, underpinned by the principles of ‘Innovation, Efficiency, and Environmental Protection’. With a cumulative investment of 2 billion yuan and spanning 2,000 acres, the park employs nearly 1,000 Cambodian-Chinese staff. Phoenix Industries, a wholly-owned subsidiary of Erkang, is located within the park. With over 300 Cambodian-Chinese employees, Phoenix Industries operates several state-of-the-art production workshops, boasting an annual capacity of 11,000 tons of caffeine, 1,000 tons of folic acid, and 30,000 tons of sodium citrate.
Looking ahead, Erkang Pharmaceutical will remain steadfast in its commitment to the pharmaceutical industry, focusing on the safety of drugs and food. The company will actively forge a new integrated pattern of ‘Intermediates + APIs + Formulations’, aiming to establish a national brand with international influence.
WHY CHOOSE US